Pascual Srivastava Vishwajyoti
Known title: CEO - Asia PacificCIK: 0001998273
Associated companies
Transaction History
| SSII | ▼ Sell | Gift | 1,000,000 | $0 | 6/4/2026 | View on chart |
| SSII | ▼ Sell | Gift | 2,000,000 | $0 | 2/20/2026 | View on chart |
| SSII | ▼ Sell | Gift | 1,000,000 | $0 | 6/4/2026 | View on chart |
| SSII | ▼ Sell | Gift | 2,000,000 | $0 | 2/20/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SSII Submits FDA Response for SSi Mantra Robotic System
SS Innovations International has submitted a response to the FDA regarding its 510(k) submission for the SSi Mantra surgical robotic system. This regulatory update addresses a request for additional information, marking a step in the approval process for the company's key product. Separately, Zacks initiated coverage of the stock with a neutral recommendation.
SSII Submits FDA Response for SSi Mantra Robotic System. SS Innovations International has submitted a response to the FDA regarding its 510(k) submission for the SSi Mantra surgical robotic system. This regulatory update addresses a request for additional information, marking a step in the approval process for the company's key product. Separately, Zacks initiated coverage of the stock with a neutral recommendation.